Estrogen prevents cardiac and vascular failure in the 'listless' zebrafish (Danio rerio) developmental model

被引:22
作者
Allgood, Ottie E., Jr. [1 ]
Hamad, Alia [1 ]
Fox, Joshua [1 ]
DeFrank, Anna [1 ]
Gilley, Ryan [1 ]
Dawson, Frederick [1 ,2 ]
Sykes, Benjamin [1 ]
Underwood, Tarenne J. [2 ]
Naylor, Rachel C. [2 ]
Briggs, Ashley A. [2 ]
Lassiter, Christopher S. [2 ]
Bell, Wade E. [1 ]
Turner, James E. [1 ]
机构
[1] Virginia Mil Inst, Dept Biol, Lexington, VA 24450 USA
[2] Roanoke Coll, Dept Biol, Roanoke, VA USA
基金
美国国家科学基金会;
关键词
Estrogen; Embryonic zebrafish; Cardiovascular system; Aromatase inhibitor; Nitric oxide; RECEPTOR MODULATORS; NITRIC-OXIDE; AROMATASE INHIBITORS; SEX STEROIDS; TISSUE; GONADECTOMY; REPLACEMENT; MECHANISMS; MENOPAUSE; INSIGHTS;
D O I
10.1016/j.ygcen.2013.04.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The presence of a robust estrogen (E2) response system throughout heart and blood vessel tissues of vertebrates, including humans, has led to the speculation that this ubiquitous hormone may play a prominent role in the health and maintenance of the adult cardiovascular system (CVS). We previously established an embryonic zebrafish model called 'listless', which results from the inhibition of E2 synthesis by treatment with aromatase enzyme inhibitors (AI). These fish have outward symptoms similar to the human condition of congestive heart failure and tamponade. E2 replacement therapy (1) reduced the severity of cardiac sac abnormalities, (2) protected heart function, (3) prevented reduction in heart size, and (4) reduced blood vessel deterioration. Nitric oxide may be a critical downstream mediator of these events. We also demonstrate that removal of fluid around the heart increases survival of AI-treated fish. These results strongly indicate the importance of E2 in the developing CVS of the zebrafish and offer a potential model for the study of its role in CVS development, maintenance, and disease conditions. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 36 条